Preview

Вестник трансплантологии и искусственных органов

Расширенный поиск

НЕДОСТАТОЧНОСТЬ ТРИКУСПИДАЛЬНОГО КЛАПАНА У РЕЦИПИЕНТОВ С ТРАНСПЛАНТИРОВАННЫМ СЕРДЦЕМ

https://doi.org/10.15825/1995-1191-2018-2-91-99

Полный текст:

Аннотация

Недостаточность трикуспидального клапана – один из наиболее распространенных вариантов патологии клапанов трансплантированного сердца. Обзор посвящен анализу современных взглядов на причины, потенциально влияющие на развитие недостаточности трикуспидального клапана трансплантированного сердца, а также способы, направленные на снижение риска его развития.

Об авторах

В. И. Орлов
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России.
Россия
123182, Москва, ул. Щукинская, д. 1.


Р. Ш. Саитгареев
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России.
Россия


А. О. Шевченко
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет); ФГБОУ ВО ««Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России.
Россия


Список литературы

1. Yusen RD, Christie JD, Edwards LB. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report – 2013; Focus Theme: Age. The Journal of Heart and Lung Transplantation. 2013; 32: 965–978. DOI: 10.1016/j.healun.2013.08.007.

2. Lund LH, Khush KK, Cherikh WS. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report – 2017; Focus Theme: Allograft ischemic time. The Journal of Heart and Lung Transplantation. 2017; 36: 1037–1046. DOI: 10.1016/j.healun.2017.07.019.

3. Готье СВ. Трансплантология: от невероятного – к очевидному. М.: Триада, 2017: 48.

4. Готье СВ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации в 2016 году (IX сообщение регистра Российского трансплантологического общества). Трансплантология: итоги и перспективы. Т. VIII. 2016 год. М.: Триада, 2017: 33–66.

5. Готье СВ, Попцова ВН, Шевченко АО. Трансплантация сердца: Руководство для врачей. М.–Тверь: Триада, 2014: 136.

6. Kim GS, Kim JJ, Kim JB. Fate of the atrioventricular valve function of the transplanted heart. Circulation Journal. 2014; 78: 1654–1660.

7. Wartig M, Tesan S, Gabe J. Tricuspid regurgitation infl uences outcome after heart transplantation. The Journal of Heart and Lung Transplantation. 2014; 33: 829–835. DOI: 10.1016/j.healun.2014.04.005.

8. Шемакин СЮ, Халилулин ТА, Федосеева АА. Недостаточность трикуспидального клапана после ортотопической трансплантации сердца. Вестник трансплантологии и искусственных органов. 2009; 11 (2): 21–24.

9. Chen RJC, Wei J, Chang CY. Tricuspid valve regurgitation and endomyocardial biopsy after orthotopic heart transplantation. Transplantation Proceedings. 2008; 40: 2603–2606.

10. Yankah AC, Musci M, Weng Y. Tricuspid valve dysfunction and surgery after orthotopic cardiac transplantation. European Journal of Cardio-Thoracic Surgery. 2000; 17: 343–348.

11. Aziz TM, Burgess M, Khafagy R. Bicaval and standard techniques in orthotopic heart transplantation: mediumterm experience in cardiac performance and survival. The Journal of Thoracic and Cardiovascular Surgery. 1999; 118: 115–122.

12. Kalra N, Copeland J, Sorrell V. Tricuspid regurgitation after orthotopic heart transplantation. Echocardiography. 2010; 27: 1–4.

13. Simone RD, Lange R, Sack FU. Atrioventricular valve insuffi ciency and atrial geometry after orthotopic heart transplantation. Annals of Thoracic Surgery. 1995; 60: 1686–1693.

14. Toyoda Y, Guy TS, Kashem A. Present status and future perspectives of heart transplantation. Circulation Journal. 2013; 77: 1097–1110.

15. Goerler H, Simon A, Warnecke G. Cardiac surgery late after heart transplantation: a safe and effective treatment option. The Journal of Cardiovascular Surgery. 2010; 140: 433–439.

16. Park KY, Park CH, Chun YB. Bicaval anastomosis reduces tricuspid regurgitation after heart transplantation. Asian Cardiovascular and Thoracic Annals. 2005; 13: 251–254.

17. Schnoor M, Schäfer T, Lühmann D, Sievers HH. Bicaval versus standard technique in orthotopic heart transplantation: a systematic review and meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. 2007; 134: 1322–1331.

18. Koch A, Remppis A, Dengler TJ. Infl uence of different implantation techniques on AV valve competence after orthotopic heart transplantation. European Journal of Cardio-Thoracic Surgery. 2005; 28: 717–723.

19. Lo CY, Chang HH, Hsu CP. Endomyocardial biopsyrelated tricuspid regurgitation after orthotopic heart transplantation: single-center experience. Journal of the Chinese Medical Association. 2007; 70: 185–192.

20. Nguyen V, Cantarovich M, Cecere R, Giannetti N. Tricuspid regurgitation after cardiac transplantation: How many biopsies are too many? The Journal of Heart and Lung Transplantation. 2005; 24: 227–231.

21. Mielniczuk L, Haddad H, Davies RA, Veinot JP. Tricuspid valve chordal tissue in endomyocardial biopsy specimens of patients with signifi cant tricuspid regurgitation. The Journal of Heart and Lung Transplantation. 2005; 24: 1586–1590.

22. Haddad F, Fisher P, Pham M. Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection. The Journal of Heart and Lung Transplantation. 2009; 28: 312–319.

23. Sipahi I, Starling RC. Cardiac allograft vasculopathy: an update. Heart Failure Clinics. 2007; 3: 87–95.

24. Bhama JK, Nguyen DQ, Scolieri S. Surgical revascularization for cardiac allograft vasculopathy: Is it still an option? The Journal of Thoracic and Cardiovascular Surgery. 2009; 137: 1488–1492.

25. Bhatia SJS, Kirshenbaum JM, Shemin RJ. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987; 76: 819–826.

26. Lewen MK, Bryg RJ, Miller LW. Tricuspid regurgitation by Doppler echocardiography after orthotopic cardiac transplantation. American Journal of Cardiology. 1987; 59: 1371–1374.

27. Kwon MH, Shemi RJ. Tricuspid valve regurgitation after heart transplantation. Annals of Cardiothoracic Surgery. 2017; 6: 270–274. DOI: 10.21037/acs.2017.04.02

28. Urbanowicz T, Michalakb M, Kociembac A. Predictors of Tricuspid Valve Anulus Dilation in a Heart Recipient Population. Transplantation Proceedings. 2016; 48: 1742–1745.

29. Berger Y, HarZahav Y, Kassif Y. Tricuspid valve regurgitation after orthotopic heart transplantation: prevalence and etiology. Journal of Transplantation. 2012; E120702. DOI: 10.1155/2012/120702.

30. Thajudeen A, Stecker EC, Shehata M. Arrhythmias after heart transplantation: mechanisms and management. Journal of the American Heart Association. 2012; E.001461. DOI: 10.1161/JAHA.112.001461

31. Tsai VW, Cooper J, Garan H. The effi cacy of implantable cardioverter-defi brillators in heart transplant recipients: results from a Multicenter Registry. Circulation. 2009; 2: 197–201.

32. Kara I, Ay Y, Yanartaş M. Does the surgical technique used in the orthotopic heart transplant affect the results regarding the rhythm? The Anatolian Journal of Cardiology. 2012; 12: 255–260.

33. Dasari TW, Pavlovic-Surjancev B, Patel N. Incidence, risk factors, and clinical outcomes of atrial fi brillation and atrial fl utter after heart transplantation. American Journal of Cardiology. 2010; 106: 737–741.

34. Locali RF, Matsuoka PK, Cherbo T. Should biatrial heart transplantation still be performed? A meta-analysis. Arquivos Brasileiros de Cardiologia. 2010; 94: 829–840.

35. McDowell DL, Hauptman PJ. Implantable defi brillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey. The Journal of Heart and Lung Transplantation. 2009; 28: 847–850.

36. Dahu MI, Hutchinson MD. What is the mechanism of the atrial arrhythmia in a patient after orthotopic heart transplantation? Journal of Cardiovascular Electrophysiology. 2012; 23: 225–227.

37. Cantillon DJ, Tarakji KG, Hu T. Long-term outcomes and clinical predictors for pacemaker requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database. Heart Rhythm. 2010; 7: 1567–1571.

38. Park YH, Song JM, Lee EY. Geometric and hemodynamic determinants of functional tricuspid regurgitation: A real-time three-dimensional echocardiography study. International Journal of Cardiology. 2008; 124: 160–165.

39. Davies RR, Russo MJ, Morgan JA. Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database. The Journal of Thoracic and Cardiovascular Surgery. 2010; 140: 700–708.

40. Marelli D, Silvestry SC, Zwas D. Modifi ed inferior vena caval anastomosis to reduce tricuspid valve regurgitation after heart transplantation. Texas Heart Institute Journal. 2007; 34: 30–35.

41. Шумаков ВИ. Трансплантация сердца: Руководство для врачей. М.: МИА, 2006: 133. Shumakov VI. Transplantacija serdca: Rukovodstvo dlja vrachej. M.: MIA, 2006: 133.

42. Fraund S, Rahimi A, Hirt S. Alternative technique of the right atrial anastomosis (cavo-atrial) in orthotopic heart transplantation. The Annals of Thoracic Surgery. 2006; 81: 381–382.

43. Huenges K, Panholzer B, Fritzsche K. Over Ten Years of Experience with a Modifi ed Right Atrial Anastomosis in Orthotopic Heart Transplantation: Follow-up and Comparison with the Biatrial and Bicaval Technique. Thoracic and Cardiovascular Surgeon. 2016. DOI: 10.1055/s0036-1584908.

44. Butler J, Stankewicz MA, Wu J. Pretransplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. The Journal of Heart and Lung Transplantation. 2005; 24: 170–177.

45. Mutlak D, Aronson D, Lessick J. Functional tricuspid regurgitation in patients with pulmonary hypertension: Is pulmonary artery pressure the only determinant of regurgitation severity? Chest. 2009: 135: 115–121.

46. Topilsky Y, Khanna A, Le Tourneau T. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circulation: Cardiovascular Imaging. 2012; 5: 314–323.

47. Kanwar M, Raina A, Aponte MP. Pulmonary hypertension in potential heart transplant recipients: current treatment strategies. Current Opinion in Organ Transplantation. 2015; 20: 570–576.

48. Atluri P, Fairman AS, MacArthur JW. Continuous fl ow left ventricular assist device implant signifi cantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence. Journal of Cardiac Surgery. 2013; 28: 770–775.

49. Herrmann G, Simon R, Haverich A. Left ventricular function, tricuspid incompetence, and incidence of coronary artery disease late after orthotopic heart transplantation. European Journal of Cardio-Thoracic Surgery. 1989; 3: 111–117.

50. Mills RM, Naftel DC, Kirklin JK. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infi ltrate. Cardiac Transplant Research Database. The Journal of Heart and Lung Transplantation. 1997; 16: 813–821.

51. Aggarwal S, Blake J, Sehgal S. Right Ventricular Dysfunction as an Echocardiographic Measure of Acute Rejection Following Heart Transplantation in Children. Pediatric Cardiology. 2017; 38: 442–447. doi: 10.1007/s00246-016-1533-1.

52. Saraiva F, Matos V, Gonçalves L. Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures. Transplantation Proceedings. 2011; 43: 1908–1912.

53. Шумаков ВИ. Болезнь коронарных артерий пересаженного сердца. М.: МИА, 2008: 160.

54. Chi NH, Chou NK, Tsao CI. Endomyocardial biopsy in heart transplantation: Schedule or event? Transplantation Proceedings. 2012; 44: 894–896.

55. Fiorelli AI, Coelho GH, Oliveira JrJL. Endomyocardial biopsy as risk factor in the development of tricuspid insuffi ciency after heart transplantation. Transplantation Proceedings. 2009; 41: 935–937.

56. Fiorelli AI, Coelho GH, Aiello VD. Tricuspid valve injury after heart transplantation due to endomyocardial biopsy: an analysis of 3550 biopsies. Transplantation Proceedings. 2012; 44: 2479–2482.

57. Fiorelli A, Coelho GB, Santos RH. Successful endomyocardial biopsy guided by transthoracic two-dimensional echocardiography. Transplantation Proceedings. 2011; 43: 225–228.

58. Strecker T, Rösch J, Weyand M. Endomyocardial biopsy for monitoring heart transplant patients: 11-yearsexperience at a German heart Center. International Journal of Clinical and Experimental Pathology. 2013; 6: 55–65.

59. Naderi N, Taghavi S, Amin A. Endomyocardial biopsy via the femoral vein using a long. Curved sheath. Transplantation Proceedings. 2017; 49: 1436–1439.

60. Kunst H, Paruchuru PK, Madden B. Bacterial endocarditis: a rare complication following orthotopic cardiac transplantation. The Journal of Heart and Lung Transplantation. 2001; 20: 483.

61. Huang HH, Chuang YC, Lee KC. Prosthetic endocarditis treated by repeated heart transplantation: report of a successful case. Transplantation Proceedings. 2012; 44: 1171–1173. DOI: 10.1016/j.transproceed.2012.01.095.

62. Готье СВ. Инфекции в трансплантологии. М.: Триада, 2010: 384.

63. Sherman-Weber S, Axelrod P, Suh B. Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transplant Infectious Disease. 2004; 6: 165–170.

64. Sliwa K, Zilla P. Rheumatic heart disease: The tip of the iceberg. Circulation. 2012; 125: 3060–3062.

65. Chi NH, Chou NK, Yu YH. Heart Transplantation in Endstage Rheumatic Heart Disease – Experience of an Endemic Area. Circulation Journal. 2014; 78: 1900–1907.


Для цитирования:


Орлов В.И., Саитгареев Р.Ш., Шевченко А.О. НЕДОСТАТОЧНОСТЬ ТРИКУСПИДАЛЬНОГО КЛАПАНА У РЕЦИПИЕНТОВ С ТРАНСПЛАНТИРОВАННЫМ СЕРДЦЕМ. Вестник трансплантологии и искусственных органов. 2018;20(2):91-99. https://doi.org/10.15825/1995-1191-2018-2-91-99

For citation:


Orlov V.I., Saitgareev R.S., Shevchenko A.O. TRICUSPID VALVE INSUFFICIENCY IN RECIPIENTS WITH TRANSPLANTED HEART. Russian Journal of Transplantology and Artificial Organs. 2018;20(2):91-99. (In Russ.) https://doi.org/10.15825/1995-1191-2018-2-91-99

Просмотров: 148


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)
ISSN 2412-6160 (Online)